In research, translation refers to the implementation of findings from basic research in the clinic or in therapeutic applications.
Detailed description
Ideally, feasibility should already be considered in the design of basic research. Only translation makes results of basic research practically accessible for people. The slogan “From bench to bedside” describes the aim of translational research.
“The DZIF particularly stands out as an institution that offers junior researchers a wealth of possibilities to build up their own networks and initiate projects themselves,” says Janne Vehreschild
An international research team led by the Research Center Borstel, developed a new method to label tubercle bacilli, the causative agents of tuberculosis with unique identifiers created from whole
Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have
German scientists from the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) in Braunschweig and Nigerian researchers are applying the new mobile
For over 20 years, Professor Andreas Peschel from the Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) and the German Center for Infection Research (DZIF) has dedicated
Chronic lung infections caused by the bacterium Pseudomonas aeruginosa require complex and, in most cases, long-term treatment with antibiotics. It is generally not possible to completely heal the
The German Council of Science and Humanities has given the German Centers for Health Research (DZG) a positive assessment in recognition of the DZG’s outstanding achievements. According to the Council
The European Medicines Agency (EMA) has granted “PRIME eligibility” to Myrcludex B, and will provide priority support for its further drug development. The hepatitis B and D virus entry inhibitor was
Dr Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, visited the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) to inform himself about multidrug-resistant pathogens
Researchers at the ImmunoSensation cluster of excellence at the University of Bonn have managed to do what many scientists dream of: together with researchers from the USA, they have patented new
